Cargando…

Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs

Background: Increasing evidence supports a neuroinflammatory basis in ADHD damaging glial function and thereby altering dopaminergic (DA) neurotransmission. Previous studies focusing on the S100B protein as a marker of glial function have shown contradictory results. We conducted a clinical trial to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouadih-Moran, Miriam, Muñoz-Hoyos, Antonio, D’Marco, Luis, Molina-Carballo, Antonio, Seiquer, Isabel, Checa-Ros, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919946/ https://www.ncbi.nlm.nih.gov/pubmed/36771418 http://dx.doi.org/10.3390/nu15030712

Ejemplares similares

Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial
por: Checa-Ros, Ana, et al.
Publicado: (2023)

Methylphenidate Ameliorates Depressive Comorbidity in ADHD Children without any Modification on Differences in Serum Melatonin Concentration between ADHD Subtypes
por: Cubero-Millán, Isabel, et al.
Publicado: (2014)

Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications
por: Checa-Ros, Ana, et al.
Publicado: (2021)

Relevance of ω-6 GLA Added to ω-3 PUFAs Supplements for ADHD: A Narrative Review
por: D’Helft, Jelle, et al.
Publicado: (2022)

Effectiveness of methylphenidate and PUFA for the treatment of patients with ADHD: A double-blinded randomized clinical trial
por: Moghaddam, Mahbobeh Firouzkouhi, et al.
Publicado: (2017)

Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
por: Banaschewski, Tobias, et al.
Publicado: (2018)

Cardioprotective Effects of ω-3 PUFAs in Chronic Kidney Disease
por: Lee, Su Mi, et al.
Publicado: (2013)

A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth
por: Van Name, Michelle A, et al.
Publicado: (2020)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD)
por: DeVito, Elise E., et al.
Publicado: (2008)

ω-3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases
por: Cittadini, Achille, et al.
Publicado: (2013)

Resveratrol and ω-3 PUFAs Promote Human Macrophage Differentiation and Function
por: Schwager, Joseph, et al.
Publicado: (2022)

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
por: Masi, Gabriele, et al.
Publicado: (2019)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

ω-3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases 2014
por: Weylandt, Karsten H., et al.
Publicado: (2015)

ω-3 PUFAs and Resveratrol Differently Modulate Acute and Chronic Inflammatory Processes
por: Schwager, Joseph, et al.
Publicado: (2015)

RA and ω-3 PUFA co-treatment activates autophagy in cancer cells
por: Zhu, Shenglong, et al.
Publicado: (2017)

A Comparison of Effectiveness of Regulation of Working Memory Function and Methylphenidate on Remediation of Attention Deficit Hyperactivity Disorder (ADHD)
por: Mohammadi, Mohammad Reza, et al.
Publicado: (2014)

Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency
por: Hammels, Ina, et al.
Publicado: (2019)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review
por: Serini, Simona, et al.
Publicado: (2017)

Polyphenols and ω-3 PUFAs: Beneficial Outcomes to Obesity and Its Related Metabolic Diseases
por: Siroma, Thais Keiko, et al.
Publicado: (2022)

Attention-Deficit/Hyperactivity Disorder Animal Model Presents Retinal Alterations and Methylphenidate Has a Differential Effect in ADHD versus Control Conditions
por: Sanches, Eliane S., et al.
Publicado: (2023)

Poor response to methylphenidate is associated with a smaller dorsal attentive network in adult Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Parlatini, Valeria, et al.
Publicado: (2023)

Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
por: Gomez-Sanchez, Clara I., et al.
Publicado: (2017)

Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial
por: Mohammadi, Mohammad Reza, et al.
Publicado: (2012)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

Role of Omega-3 Fatty Acids as Non-Photic Zeitgebers and Circadian Clock Synchronizers
por: Checa-Ros, Ana, et al.
Publicado: (2022)

Exploring the Link between Cardiorenal and Metabolic Diseases
por: D’Marco, Luis, et al.
Publicado: (2023)

PUFA ω-3 and ω-6 biomarkers and sleep: a pooled analysis of cohort studies on behalf of the Fatty Acids and Outcomes Research Consortium (FORCE)
por: Murphy, Rachel A, et al.
Publicado: (2021)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
por: D’Archivio, Massimo, et al.
Publicado: (2013)

Effects of ω-3 PUFAs Supplementation on Myocardial Function and Oxidative Stress Markers in Typical Rett Syndrome
por: Maffei, Silvia, et al.
Publicado: (2014)

Maternal PUFA ω-3 Supplementation Prevents Neonatal Lung Injuries Induced by Hyperoxia in Newborn Rats
por: Sharma, Dyuti, et al.
Publicado: (2015)

Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in Male Obesity Secondary Hypogonadism Syndrome
por: Noce, Annalisa, et al.
Publicado: (2020)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cdka4aj4b90fa04drqqmotep70